Contact this trialFirst, we need to learn more about you.
GLP-1 Receptor Agonist
Dulaglutide for Type 2 Diabetes
Recruiting2 awardsPhase 3
Tamarac, Florida
"This trial is looking at different doses of dulaglutide in children with Type 2 Diabetes to see how well they work. The study will take around 8 months to complete."
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.